BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Clin Pediatr. Mar 9, 2026; 15(1): 114152
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.114152
Mucopolysaccharidosis type VI in the Russian registry: Further insights and considerations
Sajid Malik
Sajid Malik, Department of Zoology, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad 45320, Pakistan
Author contributions: Malik S conceived the idea, wrote the manuscript, and approved the final manuscript.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Sajid Malik, PhD, Department of Zoology, Faculty of Biological Sciences, Quaid-I-Azam University, University Road, Islamabad 45320, Pakistan. malik@qau.edu.pk
Received: September 15, 2025
Revised: October 17, 2025
Accepted: December 16, 2025
Published online: March 9, 2026
Processing time: 175 Days and 3.2 Hours
Core Tip

Core Tip: This commentary highlights major methodological and reporting limitations in the recent mucopolysaccharidosis type VI Russian national registry study by Vechkasova et al, including missing statistical analyses, unclear genotype-phenotype correlations, inconsistent data reporting, and survivorship bias. Improving data transparency, variant interpretation, and clinical documentation is essential for the registry to generate reliable insights and guide patient care.

Write to the Help Desk